TONIX PHARMACEUTICALS HOLDIN (TNXP)
US8902608541 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -116.66M | -110.22M | -92.29M | -50.46M | -28.62M | |||
| Depreciation Amortization | 4.29M | 1.25M | 50.00K | 30.00K | 30.00K | |||
| Change In Working Capital | -35.00K | 0.00 | 5.78M | -2.37M | 450.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 10.40M | 10.91M | 10.90M | 4.24M | 1.46M | |||
| OPERATING CASH FLOW | -102.00M | -98.05M | -75.56M | -48.57M | -26.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -7.89M | -48.15M | -35.31M | -8.56M | -20.00K | |||
| Other Investing Activity | -21.18M | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | -29.07M | -48.15M | -35.31M | -8.56M | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 8.94M | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | 27.57M | 87.84M | 212.49M | 123.11M | 12.92M | |||
| FINANCING CASH FLOW | 36.52M | 87.84M | 212.49M | 123.11M | 12.92M | |||
| Exchange Rate Effect | -65.00K | -70.00K | -30.00K | -20.00K | 0.00 | |||
| CHANGE IN CASH | -94.62M | -58.43M | 101.59M | 65.96M | -13.78M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -102.00M | -98.05M | -75.56M | -48.57M | -26.68M | |||
| Capital Expenditure | -7.89M | -48.15M | -35.31M | -8.56M | -20.00K | |||
| FREE CASH FLOW | -109.90M | -146.20M | -110.87M | -57.13M | -26.70M | |||
All data in USD